Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220016845 220013857 1.52 69.5 Curative (C) 2016-02-19 2016-04-29 Cytarabine Low Dose N N 220026839 CYTARABINE
220016848 220007009 null 75 Curative (C) 2017-10-15 2017-10-15 CYTARABINE N N 220026878 CYTARABINE
220016850 220007014 0 null Palliative (P) 2016-09-23 2017-06-28 Hydroxycarbamide 02 N 220026886 HYDROXYCARBAMIDE
220016851 220007016 null 52 Curative (C) 2016-08-08 2016-10-21 AML MyeChild N N 220026891 NOT MATCHED
220016852 220007017 1.64 22.7 Palliative (P) 2013-05-21 2013-05-21 AML Interim Guidelines FLA -Ida N N 220026891 NOT MATCHED
220016853 220007018 1.73 null Curative (C) 2017-09-26 2017-10-17 Hydroxycarbamide 02 N 220026893 HYDROXYCARBAMIDE
220016854 220007019 null 97 Curative (C) 2016-08-25 2016-08-28 Cytarabine low (10to20mg/m2) IV/SC Y N 220026895 CYTARABINE
220016855 220013865 1.73 18.9 Curative (C) null 2017-04-09 null N N 220026899 NOT MATCHED
220016856 220007023 1.63 null Curative (C) 2015-07-25 2015-10-05 Cytarabine low (10to20mg/m2) IV/SC 1 N 220026922 CYTARABINE
220016857 220007024 null 57.2 Curative (C) 2016-01-14 2016-04-10 Cytarabine low (10to20mg/m2) IV/SC 1 N 220026923 CYTARABINE
220016858 220007025 1.15 78 Curative (C) 2016-09-17 2016-09-22 BMT Fludarabine/Thiotepa/Treosulfan + ATG N N 220026928 NOT MATCHED
220016859 220013871 null 66.7 Curative (C) 2018-05-24 2018-10-14 Cytarabine Low Dose 2 N 220026936 CYTARABINE
220016861 220007029 1.67 null Disease modification (D) 2017-01-04 2017-02-17 Cytarabine Low Dose 2 N 220026950 CYTARABINE
220016862 220013873 null 60.5 Palliative (P) 2015-03-04 2017-11-13 Cytarabine low (10to20mg/m2) IV/SC 02 N 220026951 CYTARABINE
220016863 220007032 null 62 Adjuvant (A) 2017-09-10 2017-09-11 CYTARABINE 02 N 220026952 CYTARABINE
220016864 220007034 null null Palliative (P) 2017-01-31 2017-02-06 AML MyeChild 01 IT Cyt N N 220026961 NOT MATCHED
220016865 220013875 null 88.7 Curative (C) 2015-11-14 2015-11-14 CYTARABINE N N 220026962 CYTARABINE
220016866 220013876 0 76.5 Palliative (P) 2013-10-18 2013-10-18 Hydroxycarbamide 2 N 220026963 HYDROXYCARBAMIDE
220016867 220007042 1.71 0 Palliative (P) 2015-02-03 2015-02-03 Hydroxycarbamide null null 220026967 HYDROXYCARBAMIDE
220016868 220007044 1.08 50.9 null null 2015-12-15 Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + CYCLOPHOSPHAMIDE + CYTARABINE + FLUDARABINE 2 N 220026968 NOT MATCHED
220016869 220007045 null 85.5 Palliative (P) 2019-01-14 2019-01-15 Hydroxycarbamide 02 N 220026971 HYDROXYCARBAMIDE
220016871 220007052 1.72 85 Palliative (P) null 2016-11-09 Hydroxycarbamide N 2 220026981 HYDROXYCARBAMIDE
220016872 220007054 null null Curative (C) 2016-12-28 2017-06-08 Cytarabine Low Dose N N 220027011 CYTARABINE
220016873 220007055 null 59.9 Disease modification (D) 2014-08-04 2014-09-07 Hydroxycarbamide N null 220027014 HYDROXYCARBAMIDE
220016874 220007058 1.67 109 Adjuvant (A) 2018-08-24 2018-08-24 FLUDARABINE + THIOTEPA + TREOSULFAN N N 220027025 NOT MATCHED
220016875 220007063 1.62 108.4 Disease modification (D) 2017-11-30 2017-12-02 CYTARABINE 02 N 220027033 CYTARABINE
220016876 220007064 0 null Palliative (P) 2017-12-13 2017-12-15 Hydroxycarbamide 99 N 220027042 HYDROXYCARBAMIDE
220016877 220007067 1.83 null Palliative (P) 2015-10-12 2015-10-13 Hydroxycarbamide 2 N 220027042 HYDROXYCARBAMIDE
220016878 220007067 1.81 94.6 Curative (C) 2016-12-29 2017-02-09 AML Relapsed High Dose Cytarabine Y N 220027042 NOT MATCHED
220016879 220007068 0 21.5 Curative (C) 2013-07-30 2013-10-04 null 2 N 220027059 NOT MATCHED
220016880 220007068 null 90 Palliative (P) 2017-05-08 2017-05-12 Cytarabine Low Dose N N 220027059 CYTARABINE
220016881 220007069 1.55 null Palliative (P) 2018-01-23 2018-01-24 Cytarabine Intrathecal (any age) 02 N 220027071 CYTARABINE
220016882 220007071 null 30.6 Curative (C) 2015-12-05 2015-12-05 AML MyeChild 01 Triple IT N null 220027077 NOT MATCHED
220016883 220007073 null 51 null null 2013-08-15 CYTARABINE N null 220027087 CYTARABINE
220016884 220007074 1.61 56.8 Palliative (P) null 2018-02-04 Hydroxycarbamide 02 N 220027108 HYDROXYCARBAMIDE
220016885 220019621 0 11.5 Curative (C) 2016-07-30 2016-10-26 AML MyeChild 01 Triple IT 02 N 220027115 NOT MATCHED
220016886 220007076 1.52 null null 2017-03-17 2017-03-20 CYTARABINE 2 N 220027129 CYTARABINE
220016887 220007077 0 37.05 Disease modification (D) 2017-11-23 2018-02-16 AML MyeChild 01 HD AraC 02 N 220027135 NOT MATCHED
220016888 220013900 1.66 82.6 Disease modification (D) 2015-02-20 2015-06-07 Hydroxycarbamide 01 N 220027142 HYDROXYCARBAMIDE
220016889 220007079 null 60.5 null 2016-07-06 2016-07-06 CYTARABINE N N 220027145 CYTARABINE
220016890 220007082 null null Palliative (P) 2013-11-17 2013-11-19 Hydroxycarbamide 02 N 220027147 HYDROXYCARBAMIDE
220016891 220007084 1.66 84.7 Curative (C) 2017-08-16 2017-08-16 Hydroxycarbamide 2 N 220027157 HYDROXYCARBAMIDE
220016892 220013902 1.7 55.8 Curative (C) null 2018-07-17 CYTARABINE + FLUDARABINE + IDARUBICIN + Tretinoin Gemtuzumab Ozogamicin N null 220027160 NOT MATCHED
220016893 220017566 null 61 Curative (C) 2016-05-13 2016-05-13 FLUDARABINE + THIOTEPA + TREOSULFAN 2 Y 220027170 NOT MATCHED
220016894 220007088 1.81 null Curative (C) 2016-09-14 2016-09-15 APML Consolidation I ATRA,Cytarabine,Mitoxantrone 02 N 220027179 NOT MATCHED
220016895 220007092 null 58.6 Not known (9) 2015-04-22 2015-04-25 Cytarabine Low Dose N N 220027188 CYTARABINE
220016896 220007095 1.64 45 Curative (C) null 2014-02-23 Cytarabine low (10to20mg/m2) IV/SC N N 220027205 CYTARABINE
220016897 220021488 0 15.1 Disease modification (D) 2014-06-05 2014-06-12 Cytarabine Low Dose 02 N 220027215 CYTARABINE
220016898 220021488 0 38.4 Disease modification (D) 2014-01-08 2014-01-09 AML MyeChild 01 B Cytarabine/Daunoxome 02 N 220027215 NOT MATCHED
220016899 220007097 null null Palliative (P) 2016-03-28 2016-03-31 Hydroxycarbamide 01 N 220027219 HYDROXYCARBAMIDE